Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia

被引：7
|
作者：
Bassler, Dirk [1 ]
van den Anker, John [2 ,3 ]
机构：
[1] Univ Zurich, Univ Hosp Zurich, Dept Neonatol, Frauenklin Str 10, CH-8091 Zurich, Switzerland
[2] Univ Basel, Div Paediat Pharmacol & Pharmacometr, Childrens Hosp, Spitalstr 33, CH-4056 Basel, Switzerland
[3] Childrens Natl Med Ctr, Div Clin Pharmacol, 111 Michigan Ave NorthWest, Washington, DC 20010 USA
来源：
PEDIATRIC CLINICS OF NORTH AMERICA | 2017年 / 64卷 / 06期
关键词：
Bronchopulmonary dysplasia; Inhaled corticosteroids; Inhaled bronchodilators; Systemic corticosteroids; Dexamethasone; Hydrocortisone; Pharmacology; CHRONIC LUNG-DISEASE; LOW-DOSE HYDROCORTISONE; PRETERM INFANTS; PREMATURE-INFANTS; RANDOMIZED-TRIAL; CEREBRAL-PALSY; DOUBLE-BLIND; PREVENTION; THERAPY; PHARMACOKINETICS;
D O I：
10.1016/j.pcl.2017.08.012
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
All definitions of bronchopulmonary dysplasia (BPD) have limitations, and a new definition for the purpose of clinical research, benchmarking, and prognostic prediction is needed. Different inhaled and systemic drugs are currently used to prevent or treat BPD. Despite some positive effects on BPD, more information about the effects of inhaled corticosteroids is required to assess overall efficacy and associated risks. One needs to balance the risks of neurodevelopmental impairment owing to systemic corticosteroids against those of BPD itself. Future studies should, therefore, focus on infants with a very high risk of developing BPD and include pharmacokinetics and long-term developmental outcomes.
引用
收藏
页码：1355 / +
页数：14
相关论文
共 50 条
  • [41] Pulmonary Hypertension in Bronchopulmonary Dysplasia
    Ambalavanan, Namasivayam
    Mourani, Peter
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (03) : 240 - 246
  • [42] Inhaled nitric oxide to prevent bronchopulmonary dysplasia in preterm neonates
    Mercier, Jean-Christophe
    Olivier, Paul
    Loron, Gauthier
    Fontaine, Romain
    Maury, Laure
    Baud, Olivier
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2009, 14 (01) : 28 - 34
  • [43] Bronchopulmonary Dysplasia
    Deakins, Kathleen M.
    RESPIRATORY CARE, 2009, 54 (09) : 1252 - 1262
  • [44] Clinical trials of postnatal corticosteroids: Inhaled and systemic
    Halliday, HL
    BIOLOGY OF THE NEONATE, 1999, 76 : 29 - 40
  • [45] Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD
    Ma, Nan
    Qi, Yujing
    Liang, Xiaona
    Bai, Jing
    Deng, Jingmin
    Li, Meihua
    He, Zhiyi
    FRONTIERS IN MEDICINE, 2021, 8
  • [46] Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia
    Leon, Cynara
    Martin, Amanda
    Young, Lisa R.
    Aoyama, Brianna C.
    Rice, Jessica L.
    Kelchtermans, Jelte
    Collaco, Joseph M.
    McGrath-Morrow, Sharon A.
    PEDIATRIC PULMONOLOGY, 2024, 59 (11) : 2815 - 2822
  • [47] Inhaled bronchodilator use for infants with bronchopulmonary dysplasia
    Slaughter, J. L.
    Stenger, M. R.
    Reagan, P. B.
    Jadcherla, S. R.
    JOURNAL OF PERINATOLOGY, 2015, 35 (01) : 61 - 66
  • [48] Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants
    Doyle, Lex W.
    Cheong, Jeanie L.
    Hay, Susanne
    Manley, Brett J.
    Halliday, Henry L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (10):
  • [49] Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia
    Marianne Pappagallo
    Soraya Abbasi
    Vinod K. Bhutan
    The Indian Journal of Pediatrics, 1998, 65 (2) : 273 - 282
  • [50] Presumed adrenal insufficiency in neonates treated with corticosteroids for the prevention of bronchopulmonary dysplasia
    Josephsen, Justin B.
    Hemmann, Brianna M.
    Anderson, Connie D.
    Hemmann, Brett M.
    Buchanan, Paula M.
    Williams, Howard L.
    Lubsch, Lisa M.
    Hillman, Noah H.
    JOURNAL OF PERINATOLOGY, 2022, 42 (01) : 65 - 71
12345